Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer
Regina Mbugua(Shiga University of Medical Science), Yataro Daigo(The University of Tokyo), Bayarbat Tsevegjav(Shiga University of Medical Science), Yohei Miyagi(Kanagawa Cancer Center), Atsushi Takano(The University of Tokyo), Toshinari Yamashita(Kanagawa Prefectural Hospital Organization), Tomoyuki Yokose(Kanagawa Prefectural Hospital Organization)
Cited by 2
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593